CCR7 Ligand 1 (CCR7-Cmp2105) is an allosteric Ligand and antagonist for human CC chemokine receptor 7 (CCR7) with a K d of 3 nM. CCR7 Ligand 1, thiadiazole-dioxide ligan, suppresses arrestin binding in response to activation by CCL19 with an IC 50 of 7.3 μM
In Vitro
CCR7 Ligand 1 (CCR7-Cmp2105) binds to a pocket at the intracellular part of CCR7 between the ends of TM1, TM2, TM3, and TM6 and the loop between TM7 and H8. CCR7 Ligand 1 allosterically inhibits binding of the native chemokine CCL19 ligand in scintillation proximity assays (bottom) with an IC50 of 35 nM. CCR7 Ligand 1 (20, 40, 60, 80, 100 μM) has dose-dependent thermo-stabilizing effect on CCR7. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Form:Solid
IC50& Target:Human CCR7 3 nM (Kd)
规格
别名
CCR7 配体 1
规格或纯度
≥99%
英文名称
CCR7 Ligand 1
生化机理
CCR7 配体 1(CCR7-Cmp2105)是人 CC 趋化因子受体 7(CCR7)的异位配体和拮抗剂,其 K d 为 3 nM。CCR7 配体 1 是噻二唑-二氧化物配体,在 CCL19 激活时可抑制 arrestin 结合,其 IC 50 为 7.3。